Why the study?
Does a nondipping blood pressure pattern associate with increased surrogate cardiovascular risk markers in individuals with optimal 24-hour blood pressure?
Does a nondipping blood pressure pattern associate with increased surrogate cardiovascular risk markers in individuals with optimal 24-hour blood pressure?
Answers are grounded in this paper and cite their sources.
In individuals with optimal 24-hour blood pressure, a nondipping pattern is not associated with increased subclinical target organ damage, suggesting that absolute nighttime BP may be a more relevant risk marker in this low-risk population.
Physiologically, the circadian variation of sympathetic activity presents a nadir during nighttime sleep and is accompanied by increased vagal tone and a marked reduction in heart rate, cardiac output, and total peripheral resistance. Subsequently, blood pressure (BP) drops during nighttime bed-rest period.1 Although nighttime BP dipping follows a normal distribution in a population setting, nighttime BP values are expected to normally drop by 10–20% compared with daytime values. According to recent hypertension guidelines, assessment of nocturnal BP values and dipping status is a specific indication for 24-hour ambulatory blood pressure monitoring (ABPM), which enables the classification of patients as “dippers” and “nondippers.”2 The latter comprise a significant portion of the general hypertensive population (20–40%)3,4 and are generally considered as patients at a substantially increased cardiovascular risk.2 Indeed, nondipping pattern has been associated with cardiac and extra-cardiac hypertension-mediated organ damage and adverse cardiovascular outcomes. Three decades ago, it was observed that nondippers present increased left ventricular mass index compared with dippers.5 Few years later, a prospective population-based study of community-dwelling Japanese individuals showed increased cardiovascular mortality in nondippers compared with dippers, even after adjustment for 24 hours, daytime and nighttime BP.6 These findings have been consistently confirmed by several subsequent studies providing ample evidence in favor of the aggravated cardiovascular risk profile of nondippers. Nondippers have been reported to present increased arterial stiffness7 and reduced renal function,8 whereas nocturnal systolic BP (SBP) dipping has been identified as a strong indicator of brain matter volume and cognitive function.9 In a recent meta-analysis of 2,753 individuals, nondippers exhibited more pronounced levels of subclinical atherosclerosis compared with dippers, evidenced by increased common carotid intima–media thickness (cIMT).10 Another meta-analysis of 3,591 untreated essential hypertensives recently showed increased risk of left ventricular structural alterations among nondippers.11 In a large meta-analysis of 17,312 hypertensives from 3 continents, the nocturnal BP fall, assessed with the systolic night-to-day ratio, predicted all outcomes, including total cardiovascular events, coronary events, strokes, cardiovascular mortality, and total mortality, even after adjustment for 24-hour SBP.12 Overall, mounting evidence seems to justify the classification of patients with hypertension in dippers and nondippers as an additional tool for cardiovascular risk stratification of patients with hypertension. However, it needs to be taken into account that in the majority of such studies, patients with hypertension presented increased cardiovascular risk, evidenced by the considerably increased BP levels and/or the presence of cardiovascular comorbidities. In the present issue of the American Journal of Hypertension, Lopez-Sublet et al.13 seem to challenge a well-established perception. The investigators analyzed data from 1,334 individuals with normotension and hypertension, whose mean 24-hour and daytime ABPM measurements were within the normal range. They applied several validated measures of subclinical cardiac (left ventricular mass index, left ventricular hypertrophy, and diastolic dysfunction derived from cardiac ultrasound) and renal damage (estimated glomerular filtration rate, albumin/creatinine ratio), arterial stiffness [pulse wave velocity (PWV) and central SBP] and subclinical atherosclerosis (cIMT and distensibility). Interestingly, nondipping status was consistently not associated with any of the cardiac, vascular, or renal parameters in either the hypertensive or the normotensive group. Are the findings by Lopez-Sublet et al.13 so discordant with the relevant literature? In fact, the conventional perception of dipping as a favorable clinical trait, as opposed to nondipping, has been previously questioned in relatively low-risk individuals with uncomplicated hypertension. Over the last years, the balance is being shifted from dipping status to absolute nighttime BP levels. Indeed, several studies have shown that increased nighttime BP, rather than the dipping status per se, may represent a superior early marker of subclinical organ damage mostly in cohorts without overt cardiovascular disease such as untreated, newly diagnosed hypertensives. Cuspidi et al. showed similar prevalence of subclinical target organ damage (left ventricular mass, cIMT, and urinary albumin excretion) between dippers and nondippers in their cohort of untreated patients with nocturnal hypertension.14 In the study by Androulakis et al.15 of newly diagnosed hypertensives, arterial stiffness, but not cIMT or left vetricular mass index, correlated with nondipping, but only in the nocturnal hypertension group. By contrast, the presence of nocturnal hypertension was accompanied by increased PWV, cIMT, and left ventricular mass index.15 O’Flynn et al.16 failed to identify an association between dipping status and target organ damage (albuminuria and left ventricular hypertrophy) in a primary care-based population sample. The authors concluded that absolute nighttime BP, rather than dipping status, might be a superior early marker of cardiovascular health.16 In our recent study of 222 untreated, newly diagnosed hypertensives, nondipping was accompanied by increased urinary albumin excretion, but all other measures applied for the evaluation of arterial stiffness, subclinical atherosclerosis, and endothelial dysfunction were similar between dippers and nondippers. When we further accounted for nighttime SBP, the combination of dipping with elevated nighttime SBP seemed to confer the same cardiovascular risk as nondipping, whereas dippers with normal nighttime SBP were identified as a distinct group with a lower cardiovascular risk score.17 Likewise, in our recent study of high-risk patients with rheumatoid arthritis, plain categorization to dippers and nondippers failed to reveal any differences in terms of vascular measurements, whereas the combination of a nondipping profile with high nighttime SBP was accompanied by significantly higher levels of arterial stiffness and cardiovascular risk.18 In this light, the current article by Lopez-Sublet et al.13 offers further insight on the clinical perspective of BP dipping patterns. The critical factor for the nonsignificant associations of dipping with surrogated cardiovascular risk markers may relate to the optimal BP control of the study population. Importantly, mean 24-hour BP of the population was within normal range (120 ± 10/74 ± 7 mm Hg) and did not significantly differ between dippers and nondippers, both in the normotensive and in the hypertensive group. To obtain similar 24-hour BP, dippers need to have a higher daytime BP combined with lower nighttime BP than nondippers. The authors make the logical assumption that higher BP during nighttime (8 hours/24 hours) and lower BP during daytime (16 hours/24 hours) could counterbalance the potential deleterious effect of nondipping. Alternatively, it could be hypothesized that in individuals with normotension with already low daytime BP values, there is a limited margin for nighttime BP to drop much further. In this case, nondipping might actually not represent an adverse condition. In addition, half of hypertensives in the study were diagnosed during the research visit on the basis of ABPM measurements, thus presumably free from the aggravated cardiovascular burden associated with long-term, complicated hypertension. Taken together, the current work by Lopez-Sublet et al.13 and other available studies call for a more careful consideration of dipping pattern alone as an unfavorable clinical trait. Not all nondippers seem to be by definition of equally high cardiovascular risk. Relatively low values of daytime BP, accompanied by limited BP dipping (<10%) during nighttime, may negate the theoretically detrimental effects of nondipping in terms of cardiovascular health. Therefore, patients exhibiting a nondipping profile need to be evaluated within the context of their 24-hour and daytime BP values, as well as the presence of other comorbidities and their global cardiovascular risk score. Nondipping is highly prevalent and characterizes patients with cardiovascular risk factors, such as obstructive sleep apnea, obesity, diabetes, chronic kidney disease, and old age.2 In such patients, it is likely to represent an epiphenomenon of the already high cardiovascular risk, rather a distinct cardiovascular risk factor. On the other hand, hypertensives of relatively low cardiovascular risk and without exaggerated 24-hour BP values might benefit more from the evaluation of other parameters provided by ABPM, such as absolute values of nighttime BP, the presence of nocturnal hypertension, reverse dipping, or even the combination of dipping patterns with elevated nighttime BP, rather than dipping pattern alone. However, the study by Lopez-Sublet et al.13 is not devoid of limitations. Their findings were based on a single 24-hour ABPM session, yet doubts have been raised regarding the reproducibility of nighttime BP dipping.4 Most importantly, it is unfortunate that even though subjects were initially healthy at study enrollment and prospectively followed, ABPM was not performed in the inaugural visit. Hence, the whole study design is confined in a cross-sectional analysis of a single visit. Finally, generalizability of their results to populations with different BP levels and divergent clinical traits cannot be supported. Overall, this study does not necessarily negate the detrimental effects of nondipping in essential hypertension but rather calls for a more careful consideration and logical critique of the clinical perspective of dipping in different clinical settings. Even though the clinical relevance of nondipping might fade under optimal BP control, it is critical to evaluate other ABPM components (i.e., nighttime BP, nocturnal hypertension, and reverse dipping) with incremental value in terms of cardiovascular prognosis. In any case, the clinical impact of nighttime dipping warrants much more extensive investigation with prospective, randomized studies, rather than the widely applied observational studies of cross-sectional design. The authors declared no conflicts of interest.
No takes yet. Share an insight, caveat, or question.
Gkaliagkousi et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: